SlideShare a Scribd company logo
CDISC Standard Data Tabulation Module Domain Construction Trial Design Domains Presented By: Ankur Sharma Biostatistical Programmer PAREXEL International Baltimore, MD, USA
Review ,[object Object],[object Object],[object Object],[object Object],[object Object]
Trial Design Datasets: ,[object Object],[object Object]
Trial Arms (TA) ,[object Object],[object Object],[object Object]
STUDYID & DOMAIN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ARMCD & ARM ,[object Object]
Continued…. ,[object Object],[object Object]
TAETORD ,[object Object],[object Object],[object Object]
Continued…. ,[object Object],[object Object]
ETCD ,[object Object],[object Object]
ELEMENT ,[object Object],[object Object]
Continued…. ,[object Object],[object Object]
TABRANCH ,[object Object]
TATRANS ,[object Object]
Continued…. ,[object Object]
EPOCH ,[object Object],[object Object]
Trial Elements (TE) ,[object Object],[object Object]
TESTRL ,[object Object],[object Object],[object Object]
Continued…. ,[object Object]
TEENRL ,[object Object],[object Object]
Continued…. ,[object Object],[object Object]
TEDUR ,[object Object],[object Object]
Trial Visit ,[object Object],[object Object],[object Object]
Continued…. ,[object Object],[object Object]
VISITNUM & VISIT ,[object Object],[object Object]
VISITDY ,[object Object],[object Object],[object Object]
ARMCD & ARM ,[object Object]
TVSTRL ,[object Object],[object Object]
TVENRL ,[object Object],[object Object]

More Related Content

What's hot

Introduction to SDTM
Introduction to SDTMIntroduction to SDTM
Introduction to SDTM
Devender Palsa
 
Finding everything about findings about (fa)
Finding everything about findings about (fa)Finding everything about findings about (fa)
Finding everything about findings about (fa)Ram Gali
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation modelrahulrabbit
 
CDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataCDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataAngelo Tinazzi
 
define_xml_tutorial .ppt
define_xml_tutorial .pptdefine_xml_tutorial .ppt
define_xml_tutorial .ppt
ssuser660bb1
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
Vijayaraghava Karpurapu
 
Post-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDAPost-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDA
Brook White, PMP
 
How to validate sdtm suppqual
How to validate sdtm suppqualHow to validate sdtm suppqual
How to validate sdtm suppqualKevin Lee
 
regulatory.pptx
regulatory.pptxregulatory.pptx
regulatory.pptx
ssuser660bb1
 
SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets
Angelo Tinazzi
 
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONINTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONAngelo Tinazzi
 
A complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create oneA complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create one
Kevin Lee
 
SDTM Fnal Detail Training
SDTM Fnal Detail TrainingSDTM Fnal Detail Training
SDTM Fnal Detail Training
VasantRaghuraman
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
Angelo Tinazzi
 
THE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSIONTHE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSION
Angelo Tinazzi
 
CDISC-CDASH
CDISC-CDASHCDISC-CDASH
CDISC-CDASH
Gowthami6789
 
CDISC Electronic Submission to FDA
CDISC Electronic Submission to FDACDISC Electronic Submission to FDA
CDISC Electronic Submission to FDA
Kevin Lee
 
Interpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationInterpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationAngelo Tinazzi
 
CDISC journey in solid tumor using recist 1.1 (Paper)
CDISC journey in solid tumor using recist 1.1 (Paper)CDISC journey in solid tumor using recist 1.1 (Paper)
CDISC journey in solid tumor using recist 1.1 (Paper)Kevin Lee
 

What's hot (20)

Introduction to SDTM
Introduction to SDTMIntroduction to SDTM
Introduction to SDTM
 
Finding everything about findings about (fa)
Finding everything about findings about (fa)Finding everything about findings about (fa)
Finding everything about findings about (fa)
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation model
 
CDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival dataCDISC SDTM and ADaM for survival data
CDISC SDTM and ADaM for survival data
 
define_xml_tutorial .ppt
define_xml_tutorial .pptdefine_xml_tutorial .ppt
define_xml_tutorial .ppt
 
SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
 
ADaM
ADaMADaM
ADaM
 
Post-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDAPost-lock Data Flow: From CRF to FDA
Post-lock Data Flow: From CRF to FDA
 
How to validate sdtm suppqual
How to validate sdtm suppqualHow to validate sdtm suppqual
How to validate sdtm suppqual
 
regulatory.pptx
regulatory.pptxregulatory.pptx
regulatory.pptx
 
SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets
 
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATIONINTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
INTERPRETING CDISC ADaM IG THROUGH USERS INTERPRETATION
 
A complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create oneA complex ADaM dataset - three different ways to create one
A complex ADaM dataset - three different ways to create one
 
SDTM Fnal Detail Training
SDTM Fnal Detail TrainingSDTM Fnal Detail Training
SDTM Fnal Detail Training
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
 
THE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSIONTHE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSION
 
CDISC-CDASH
CDISC-CDASHCDISC-CDASH
CDISC-CDASH
 
CDISC Electronic Submission to FDA
CDISC Electronic Submission to FDACDISC Electronic Submission to FDA
CDISC Electronic Submission to FDA
 
Interpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationInterpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users Interpretation
 
CDISC journey in solid tumor using recist 1.1 (Paper)
CDISC journey in solid tumor using recist 1.1 (Paper)CDISC journey in solid tumor using recist 1.1 (Paper)
CDISC journey in solid tumor using recist 1.1 (Paper)
 

Viewers also liked

Strategies for Implementing CDISC
Strategies for Implementing CDISCStrategies for Implementing CDISC
Strategies for Implementing CDISC
jbarag
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aYawo Akrodou
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...
John Cai
 
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
ipposi
 
Implementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics DepartmentImplementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics Department
SGS
 
Patient Registries
Patient RegistriesPatient Registries
Patient Registries
mednetone
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
ipposi
 
Can CER and Personalized Medicine Work Together
Can CER and Personalized Medicine Work TogetherCan CER and Personalized Medicine Work Together
Can CER and Personalized Medicine Work TogetherJohn Cai
 
Using Healthcare Data for Research @ The Hyve - Campus Party 2016
Using Healthcare Data for Research @ The Hyve - Campus Party 2016Using Healthcare Data for Research @ The Hyve - Campus Party 2016
Using Healthcare Data for Research @ The Hyve - Campus Party 2016
Kees van Bochove
 
Pathway 2.0 for RWE and MA 2015 -John Cai
Pathway 2.0 for RWE and MA 2015 -John CaiPathway 2.0 for RWE and MA 2015 -John Cai
Pathway 2.0 for RWE and MA 2015 -John CaiJohn Cai
 
operationalizing asthma analytic plan using omop cdm brandt
operationalizing asthma analytic plan using omop cdm brandtoperationalizing asthma analytic plan using omop cdm brandt
operationalizing asthma analytic plan using omop cdm brandt
Marion Sills
 
Continuous integration: the architecture of open source application
Continuous integration: the architecture of open source applicationContinuous integration: the architecture of open source application
Continuous integration: the architecture of open source application김진태 Jintae Kim
 
Big Data Analytics for Treatment Pathways John Cai
Big Data Analytics for Treatment Pathways John CaiBig Data Analytics for Treatment Pathways John Cai
Big Data Analytics for Treatment Pathways John CaiJohn Cai
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
Rohit K.
 
Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...
Health Catalyst
 
Predictive analytics for personalized healthcare
Predictive analytics for personalized healthcarePredictive analytics for personalized healthcare
Predictive analytics for personalized healthcareJohn Cai
 
CDSCO and ADR reporting in India
CDSCO and ADR reporting in IndiaCDSCO and ADR reporting in India
CDSCO and ADR reporting in India
kiran pala
 
21 cfr part 11 compliance
21 cfr part 11 compliance21 cfr part 11 compliance
21 cfr part 11 compliance
Kiran Kota
 

Viewers also liked (18)

Strategies for Implementing CDISC
Strategies for Implementing CDISCStrategies for Implementing CDISC
Strategies for Implementing CDISC
 
AkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2aAkrodouY-Week7 Project Part 2a
AkrodouY-Week7 Project Part 2a
 
Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...Personalized Medicine in clinical drug development: opportunities for Biomedi...
Personalized Medicine in clinical drug development: opportunities for Biomedi...
 
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
Patients Driving Health Innovation - Kevin Whelan Fighting Blindness - Octobe...
 
Implementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics DepartmentImplementation of CDISC ADAM in The Pharmacokinetics Department
Implementation of CDISC ADAM in The Pharmacokinetics Department
 
Patient Registries
Patient RegistriesPatient Registries
Patient Registries
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
 
Can CER and Personalized Medicine Work Together
Can CER and Personalized Medicine Work TogetherCan CER and Personalized Medicine Work Together
Can CER and Personalized Medicine Work Together
 
Using Healthcare Data for Research @ The Hyve - Campus Party 2016
Using Healthcare Data for Research @ The Hyve - Campus Party 2016Using Healthcare Data for Research @ The Hyve - Campus Party 2016
Using Healthcare Data for Research @ The Hyve - Campus Party 2016
 
Pathway 2.0 for RWE and MA 2015 -John Cai
Pathway 2.0 for RWE and MA 2015 -John CaiPathway 2.0 for RWE and MA 2015 -John Cai
Pathway 2.0 for RWE and MA 2015 -John Cai
 
operationalizing asthma analytic plan using omop cdm brandt
operationalizing asthma analytic plan using omop cdm brandtoperationalizing asthma analytic plan using omop cdm brandt
operationalizing asthma analytic plan using omop cdm brandt
 
Continuous integration: the architecture of open source application
Continuous integration: the architecture of open source applicationContinuous integration: the architecture of open source application
Continuous integration: the architecture of open source application
 
Big Data Analytics for Treatment Pathways John Cai
Big Data Analytics for Treatment Pathways John CaiBig Data Analytics for Treatment Pathways John Cai
Big Data Analytics for Treatment Pathways John Cai
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
 
Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...
 
Predictive analytics for personalized healthcare
Predictive analytics for personalized healthcarePredictive analytics for personalized healthcare
Predictive analytics for personalized healthcare
 
CDSCO and ADR reporting in India
CDSCO and ADR reporting in IndiaCDSCO and ADR reporting in India
CDSCO and ADR reporting in India
 
21 cfr part 11 compliance
21 cfr part 11 compliance21 cfr part 11 compliance
21 cfr part 11 compliance
 

Similar to Trial Design Domains

trail design.pdf
trail design.pdftrail design.pdf
trail design.pdf
SukumarReddy43
 
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.pptcdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
poonamshukla311
 
Chap 3 (1) (1).pdf
Chap 3 (1) (1).pdfChap 3 (1) (1).pdf
Chap 3 (1) (1).pdf
ANNGUYEN90427
 
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptxNONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
Rameshwar Dass
 
Optimal rule set generation using pso algorithm
Optimal rule set generation using pso algorithmOptimal rule set generation using pso algorithm
Optimal rule set generation using pso algorithm
csandit
 
Design and analysis of ra sort
Design and analysis of ra sortDesign and analysis of ra sort
Design and analysis of ra sort
ijfcstjournal
 
Universal Domain Common observation 20080808
Universal Domain Common observation 20080808Universal Domain Common observation 20080808
Universal Domain Common observation 20080808ash84
 
Name IDPractical Data MiningCOMP-321BTutorial 5.docx
Name IDPractical Data MiningCOMP-321BTutorial 5.docxName IDPractical Data MiningCOMP-321BTutorial 5.docx
Name IDPractical Data MiningCOMP-321BTutorial 5.docx
rosemarybdodson23141
 
panel regression.pptx
panel regression.pptxpanel regression.pptx
panel regression.pptx
Victoria Bozhenko
 
Optimization Of Fuzzy Bexa Using Nm
Optimization Of Fuzzy Bexa Using NmOptimization Of Fuzzy Bexa Using Nm
Optimization Of Fuzzy Bexa Using Nm
Ashish Khetan
 
ders 6 Panel data analysis.pptx
ders 6 Panel data analysis.pptxders 6 Panel data analysis.pptx
ders 6 Panel data analysis.pptx
Ergin Akalpler
 
Overview of verilog
Overview of verilogOverview of verilog
Overview of verilog
Raghu Veer
 
ders 3.3 Unit root testing section 3 .pptx
ders 3.3 Unit root testing section 3 .pptxders 3.3 Unit root testing section 3 .pptx
ders 3.3 Unit root testing section 3 .pptx
Ergin Akalpler
 
Using computable phenotypes in point of care clinical trial recruitment
Using computable phenotypes in point of care clinical trial recruitmentUsing computable phenotypes in point of care clinical trial recruitment
Using computable phenotypes in point of care clinical trial recruitment
Martin Chapman
 
20080609 Loinc Workshop
20080609   Loinc Workshop20080609   Loinc Workshop
20080609 Loinc Workshop
dvreeman
 
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
BRNSS Publication Hub
 
Eviews forecasting
Eviews forecastingEviews forecasting
Eviews forecasting
Rafael Bustamante Romaní
 
Your Paper was well written, however; I need you to follow the f
Your Paper was well written, however; I need you to follow the fYour Paper was well written, however; I need you to follow the f
Your Paper was well written, however; I need you to follow the f
rochellscroop
 

Similar to Trial Design Domains (20)

trail design.pdf
trail design.pdftrail design.pdf
trail design.pdf
 
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.pptcdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
cdiscsdtmtrainingpresentation-12900042423172-phpapp01.ppt
 
Chap 3 (1) (1).pdf
Chap 3 (1) (1).pdfChap 3 (1) (1).pdf
Chap 3 (1) (1).pdf
 
Chap 3 (1).pdf
Chap 3 (1).pdfChap 3 (1).pdf
Chap 3 (1).pdf
 
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptxNONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
NONMEM Mixed Effects Modeling M. Pharm, B. Pharm.pptx
 
Optimal rule set generation using pso algorithm
Optimal rule set generation using pso algorithmOptimal rule set generation using pso algorithm
Optimal rule set generation using pso algorithm
 
Design and analysis of ra sort
Design and analysis of ra sortDesign and analysis of ra sort
Design and analysis of ra sort
 
Universal Domain Common observation 20080808
Universal Domain Common observation 20080808Universal Domain Common observation 20080808
Universal Domain Common observation 20080808
 
Arellano bond
Arellano bondArellano bond
Arellano bond
 
Name IDPractical Data MiningCOMP-321BTutorial 5.docx
Name IDPractical Data MiningCOMP-321BTutorial 5.docxName IDPractical Data MiningCOMP-321BTutorial 5.docx
Name IDPractical Data MiningCOMP-321BTutorial 5.docx
 
panel regression.pptx
panel regression.pptxpanel regression.pptx
panel regression.pptx
 
Optimization Of Fuzzy Bexa Using Nm
Optimization Of Fuzzy Bexa Using NmOptimization Of Fuzzy Bexa Using Nm
Optimization Of Fuzzy Bexa Using Nm
 
ders 6 Panel data analysis.pptx
ders 6 Panel data analysis.pptxders 6 Panel data analysis.pptx
ders 6 Panel data analysis.pptx
 
Overview of verilog
Overview of verilogOverview of verilog
Overview of verilog
 
ders 3.3 Unit root testing section 3 .pptx
ders 3.3 Unit root testing section 3 .pptxders 3.3 Unit root testing section 3 .pptx
ders 3.3 Unit root testing section 3 .pptx
 
Using computable phenotypes in point of care clinical trial recruitment
Using computable phenotypes in point of care clinical trial recruitmentUsing computable phenotypes in point of care clinical trial recruitment
Using computable phenotypes in point of care clinical trial recruitment
 
20080609 Loinc Workshop
20080609   Loinc Workshop20080609   Loinc Workshop
20080609 Loinc Workshop
 
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
Investigation of Parameter Behaviors in Stationarity of Autoregressive and Mo...
 
Eviews forecasting
Eviews forecastingEviews forecasting
Eviews forecasting
 
Your Paper was well written, however; I need you to follow the f
Your Paper was well written, however; I need you to follow the fYour Paper was well written, however; I need you to follow the f
Your Paper was well written, however; I need you to follow the f
 

Trial Design Domains

  • 1. CDISC Standard Data Tabulation Module Domain Construction Trial Design Domains Presented By: Ankur Sharma Biostatistical Programmer PAREXEL International Baltimore, MD, USA
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.